Clare J Lee Selected Research

Glucose (Dextrose)

11/2023	Improved Glycaemic and Weight Management Are Associated with Better Quality of Life in People with Type 2 Diabetes Treated with Tirzepatide.
3/2023	Tirzepatide as Monotherapy Improved Markers of Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes (SURPASS-1).
10/2021	Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial.
3/2020	The relationship of acculturation to cardiovascular disease risk factors among U.S. South Asians: Findings from the MASALA study.
1/2019	Validation of the Use of Electronic Medical Records for Identification of Post-gastric Bypass Hypoglycemia Cases.
7/2017	The effect of vitamin D supplementation on glucose metabolism in type 2 diabetes mellitus: A systematic review and meta-analysis of intervention studies.
7/2013	Hormonal response to a mixed-meal challenge after reversal of gastric bypass for hypoglycemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Clare J Lee Research Topics

Disease

8	Type 2 Diabetes Mellitus (MODY) 04/2024 - 07/2017
8	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 07/2013
7	Weight Loss (Weight Reduction) 12/2023 - 11/2016
3	Obesity 01/2022 - 01/2016
2	Body Weight (Weight, Body) 04/2024 - 12/2023
2	Insulin Resistance 03/2023 - 01/2020
1	Body Weight Changes 01/2024
1	Weight Gain 01/2022
1	Vomiting 10/2021
1	Nausea 10/2021
1	Prediabetic State (Prediabetes) 03/2020
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Body-Weight Trajectory 10/2017
1	Vitamin D Deficiency 07/2017
1	Hyperlipidemias (Hyperlipidemia) 11/2016
1	Overweight 01/2016
1	Fatty Liver 01/2015
1	Hypertension (High Blood Pressure) 01/2015
1	Congenital Hyperinsulinism 07/2013

Drug/Important Bio-Agent (IBA)

7	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 07/2013
6	tirzepatideIBA 04/2024 - 10/2021
6	Insulin (Novolin)FDA Link 03/2023 - 07/2013
4	Peptides (Polypeptides)IBA 11/2023 - 07/2013
3	Glucagon-Like Peptide-1 ReceptorIBA 11/2023 - 10/2021
3	Hormones (Hormone)IBA 01/2022 - 07/2013
2	LipidsIBA 04/2024 - 01/2016
2	Hypoglycemic Agents (Hypoglycemics)IBA 03/2023 - 05/2015
2	IncretinsIBA 01/2022 - 07/2013
1	semaglutideIBA 04/2024
1	insulin degludecIBA 04/2024
1	Metformin (Glucophage)FDA LinkGeneric 04/2024
1	Insulin-Like Growth Factor Binding Protein 2IBA 03/2023
1	AdiponectinIBA 03/2023
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	Growth Differentiation Factor 15IBA 01/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 10/2019
1	16S Ribosomal RNAIBA 10/2019
1	C-PeptideIBA 01/2018
1	AntibodiesIBA 01/2018
1	islet cell antibodyIBA 01/2018
1	1,5-anhydroglucitolIBA 12/2017
1	Antidepressive Agents (Antidepressants)IBA 12/2017
1	Blood Glucose (Blood Sugar)IBA 07/2017
1	Hemoglobins (Hemoglobin)IBA 07/2017
1	Vitamin D FDA LinkGeneric 07/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2013

Therapy/Procedure

9	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2022 - 07/2013
9	Bariatric Surgery 10/2019 - 01/2015
3	Glycemic Control 04/2024 - 12/2017
3	Gastrectomy 01/2022 - 05/2015
2	Therapeutics 04/2024 - 10/2021
1	Injections 10/2021
1	Activities of Daily Living (ADL) 12/2017